David Nassif - Feb 8, 2022 Form 4 Insider Report for Sio Gene Therapies Inc. (SIOX)

Role
Interim CEO, CFO, Director
Signature
/s/ David Nassif
Stock symbol
SIOX
Transactions as of
Feb 8, 2022
Transactions value $
$0
Form type
4
Date filed
2/10/2022, 04:05 PM
Previous filing
Dec 9, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SIOX Restricted Stock Units Award $0 +547K $0.00 547K Feb 8, 2022 Common Stock 547K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the right to receive one share of the Issuer's common stock.
F2 One-third of the restricted stock units shall vest on February 8, 2023, February 8, 2024 and February 8, 2025, subject to the Reporting Person providing continuous service to the Issuer through each such date.